Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kura Oncology (KURA) EPS (Basic) (2023 - 2025)

Kura Oncology (KURA) has disclosed EPS (Basic) for 3 consecutive years, with -$194.31 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) fell 88223.68% to -$194.31 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$361.8 through Dec 2025, down 17722.8% year-over-year, with the annual reading at -$3.18 for FY2025, 57.43% down from the prior year.
  • EPS (Basic) for Q4 2025 was -$194.31 at Kura Oncology, down from -$88.17 in the prior quarter.
  • The five-year high for EPS (Basic) was -$0.22 in Q4 2024, with the low at -$194.31 in Q4 2025.
  • Average EPS (Basic) over 3 years is -$30.49, with a median of -$0.59 recorded in 2024.
  • The sharpest move saw EPS (Basic) surged 60.0% in 2024, then tumbled 88223.68% in 2025.
  • Over 3 years, EPS (Basic) stood at -$0.55 in 2023, then soared by 60.0% to -$0.22 in 2024, then crashed by 88223.68% to -$194.31 in 2025.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at -$194.31, -$88.17, and -$78.66 for Q4 2025, Q3 2025, and Q2 2025 respectively.